G-Ba Does not Adjust Evidence Requirements in Early Benefit Assessment in Cases of Pre-Defined, Efficacy-Based Cross-Over Decisions in Oncology Trials
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.1334
https://www.valueinhealthjournal.com/article/S1098-3015(15)03410-5/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
829
First Page :
A486
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03410-5&doi=10.1016/j.jval.2015.09.1334